In the third quarter, organic sales rose 3% driven by increased demand for COVID-19 related products. The company significantly increased growth investments and improved market positions and achieved cost savings. Despite lower earnings as anticipated, the company raised its full-year outlook, expecting net sales to rise 2-3% and adjusted earnings per share to range from $7.50 to $7.65, indicating a year-on-year growth of 9-11%. Consumer Tissue and Personal Care saw organic sales grow 10% and 5%, respectively, while K-C Professional sales declined 15%. The company achieved excellent cost savings, totaling $140 million, and allocated capital in shareholder-friendly ways, with dividends and share repurchases reaching $560 million in the third quarter and expected to total $2.15 billion for the full year.